Inventor · disambiguated record
Sarah Williams
Also filed as: WILLIAMS SARAH · WILLIAMS SARAH LOUISE
13 granted patents·6 pending applications·64 citations·filing 2015–2022
90Inventor score
Top patents by PatentIndex Score
19 records- 0192US11466048B23′ end caps, 5′ end caps and combinations thereof for therapeutic RNANOVARTIS AG·Filed 2020·Granted Oct 11, 2022·3 cites·5 claims
- 0292US10968235B2N-azaspirocycloalkane substituted N-heteroaryl compounds and compositions for inhibiting the activity of SHP2NOVARTIS AG·Filed 2019·Granted Apr 6, 2021·3 cites·3 claims
- 0392US10077276B2N-azaspirocycloalkane substituted N-heteroaryl compounds and compositions for inhibiting the activity of SHP2CHEN CHRISTINE HIU TUNG·Filed 2015·Granted Sep 18, 2018·15 cites·22 claims
- 0490US10336774B2N-azaspirocycloalkane substituted N-heteroaryl compounds and compositions for inhibiting the activity of SHP2NOVARTIS AG·Filed 2018·Granted Jul 2, 2019·7 cites·22 claims
- 0590US10093646B21-pyridazin-/triazin-3-yl-piper(-azine)/idine/pyrolidine derivatives and compositions thereof for inhibiting the activity of SHP2CHEN CHRISTINE HIU TUNG·Filed 2015·Granted Oct 9, 2018·7 cites·10 claims
- 0690US9815813B21-(triazin-3-yl/pyridazin-3-yl)-piper(-azine)idine derivatives and compositions therefor for inhibiting the activity of SHP2CHEN ZHUOLIANG·Filed 2015·Granted Nov 14, 2017·13 cites·8 claims
- 0788US10676499B23′ end caps, 5′ end caps and combinations thereof for therapeutic RNANOVARTIS AG·Filed 2015·Granted Jun 9, 2020·6 cites·2 claims
- 0888US10301278B21-(triazin-3-yl/pyridazin-3-yl)-piper(-azine)idine derivatives and compositions therefor for inhibiting the activity of SHP2NOVARTIS AG·Filed 2017·Granted May 28, 2019·8 cites·7 claims
- 0981US10975080B2Compounds and compositions for inhibiting the activity of SHP2NOVARTIS AG·Filed 2016·Granted Apr 13, 2021·2 cites·3 claims
- 1077US2022073537A1N-azaspirocycloalkane substituted n-heteroaryl compounds and compositions for inhibiting the activity of shp2NOVARTIS AG·Filed 2021·Application pending·0 cites
- 1175US11952386B2N-azaspirocycloalkane substituted N-heteroaryl compounds and compositions for inhibiting the activity of SHP2NOVARTIS AG·Filed 2021·Granted Apr 9, 2024·0 cites·12 claims
- 1275US2022348553A11-pyridazin-/triazin-3-yl-piper(-azine)/idine/pyrolidine derivatives and compositions thereof for inhibiting the activity of shp2NOVARTIS AG·Filed 2022·Application pending·0 cites
- 1374US12209098B2N-azaspirocycloalkane substituted N-heteroaryl compounds and compositions for inhibiting the activity of SHP2NOVARTIS AG·Filed 2021·Granted Jan 28, 2025·0 cites·26 claims
- 1473US2023183286A1Novel 3' end caps, 5' end caps and combinations thereof for therapeutic rnaNOVARTIS AG·Filed 2022·Application pending·0 cites
- 1569US11401259B21-Pyridazin-/triazin-3-yl-piper(-azine)/idine/pyrolidine derivatives and compositions thereof for inhibiting the activity of SHP2NOVARTIS AG·Filed 2020·Granted Aug 2, 2022·0 cites·4 claims
- 1666US2021309663A1Compounds and compositions for inhbiting the activity of shp2NOVARTIS AG·Filed 2021·Application pending·0 cites
- 1765US2022089597A1Compounds and compositions for inhbiting the activity of shp2NOVARTIS AG·Filed 2021·Application pending·0 cites
- 1864US10774065B21-pyridazin-/triazin-3-yl-piper(-azine)/idine/pyrolidine derivatives and compositions thereof for inhibiting the activity of SHP2CHEN CHRISTINE HIU TUNG·Filed 2018·Granted Sep 15, 2020·0 cites·3 claims
- 1936US2018318311A1Tricyclic 2-quinolinones as antibacterialsNOVARTIS AG·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Sarah Williams files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →